11 completed, 2 active not recruiting, 2 withdrawn, 1 enrolling by invitation. 7 Phase 2, 4 Phase 3, 3 Phase 4, 2 Phase 1.
Follow abaloparatide: new trials by email Literature Review of abaloparatide trials Research Report on abaloparatide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Osteoporotic Medications on Vertebral Bone Quality Score Abaloparatide - Lumbar Degenerative Disease | Phase 2 | Enrolling by invitation | State University of New York at Buffalo | 60 | 2026-06-18 | 2026-07-23 |
| Supracondylar Distal Femur Fractures and Abaloparatide Abaloparatide, Placebo - Femoral Fractures | Phase 4 | Withdrawn | Daniel Horwitz | 2024-06-01 | 2024-05-01 | |
| Sequential Therapies After Osteoanabolic Treatment Zoledronate, Denosumab, Teriparatide - Osteoporosis, Postmenopausal | Recruiting | 424 General Military Hospital | 150 | 2023-11-25 | 2026-07-22 | |
| PTH Analog Type II Odontoid Fracture Abaloparatide, Hard collar immobilization - Odontoid Fracture | Phase 2 | Terminated | David Lunardini | 22 | 2022-05-18 | 2024-09-19 |
| Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women Abaloparatide, Teriparatide - Osteoporosis, Postmenopausal | Completed | Radius Health, Inc. | 22054 | 2021-07-01 | 2024-04-19 | |
| Effect of Abaloparatide on Lumbar Disc Degeneration Abaloparatide, Placebo - Degeneration Disc Intervertebral | Phase 2 | Withdrawn | Johns Hopkins University | 2021-03-01 | 2021-04-12 | |
| Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone Denosumab Injection, Abaloparatide - Osteoporosis, Postmenopausal | Phase 4 | Active not recruiting | Hospital for Special Surgery, New York | 70 | 2021-02-01 | 2026-10-13 |
| Study to Evaluate and Compare the PK Profiles of Abaloparatide-SC and Abaloparatide-sMTS in a Cohort of Healthy Men and Healthy Women. abaloparatide-sMTS, abaloparatide-SC - Healthy Volunteers | Phase 1 | Completed | Radius Health, Inc. | 52 | 2020-11-16 | 2022-01-06 |
| Abaloparatide and Pelvic Fracture Healing Abaloparatide 80 micrograms per Pen dose, Placebo prefilled injector pen - Fracture of Pelvis (Disorder) | Phase 2 | Completed | Hospital for Special Surgery, New York | 48 | 2020-09-17 | 2024-06-14 |
| Abaloparatide Before Total Knee Arthroplasty Abaloparatide - Osteoporosis, Arthroplasties, Knee Replacement | Phase 4 | Completed | University of Wisconsin, Madison | 58 | 2020-01-10 | 2026-06-05 |
| Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery Abaloparatide, Placebo - Spinal Fusion | Phase 2 | Active not recruiting | Hospital for Special Surgery, New York | 96 | 2019-08-14 | 2026-09-28 |
| Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis abaloparatide, abaloparatide solid microstructured transdermal system - Postmenopausal Osteoporosis | Phase 3 | Completed | Radius Health, Inc. | 511 | 2019-08-05 | 2023-02-15 |
| A Phase I Pilot Study of Abaloparatide + Bevacizumab in Myelodysplastic Syndromes abaloparatide, bevacizumab - Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia | Phase 1 | Completed | University of Rochester | 20 | 2019-02-14 | 2023-01-23 |
| Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption Abaloparatide - Osteoporosis, Postmenopausal, Osteoporosis | Phase 3 | Completed | Radius Health, Inc. | 23 | 2018-09-20 | 2021-10-15 |
| Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM) Abaloparatide, Placebo - Osteoporosis, Osteoporosis, Age-Related | Phase 3 | Completed | Radius Health, Inc. | 228 | 2018-05-03 | 2023-04-07 |
| Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosis Abaloparatide Transdermal (50 mcg), Abaloparatide Transdermal (100 mcg), Abaloparatide Transdermal (150 mcg) - Post Menopausal Osteoporosis | Phase 2 | Completed | Radius Health, Inc. | 250 | 2012-09-25 | 2020-06-16 |
| Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women Placebo, BA058 80 mcg, teriparatide - Osteoporosis, Postmenopausal Osteoporosis | Phase 3 | Completed | Radius Health, Inc. | 2463 | 2011-04-01 | 2017-03-01 |
| Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis teriparatide, Placebo, BA058 20 µg - Osteoporosis | Phase 2 | Completed | Radius Health, Inc. | 222 | 2007-04-01 | 2017-10-30 |
Osteoporosis (9) · Osteoporosis, Postmenopausal (7) · Bone Diseases, Metabolic (5) · Fractures, Bone (5) · Femoral Fractures (1) · Hip Fractures (1) · Intervertebral Disc Degeneration (1) · Leukemia, Myelomonocytic, Chronic (1) · Low Back Pain (1) · Motor Activity (1) · Myelodysplastic Syndromes (1) · Osteoporotic Fractures (1) · Pain (1)
Radius Health, Inc. (8) · Hospital for Special Surgery, New York (3) · 424 General Military Hospital (1) · Daniel Horwitz (1) · David Lunardini (1) · Johns Hopkins University (1) · State University of New York at Buffalo (1) · University of Rochester (1) · University of Wisconsin, Madison (1)
United States (17) · Poland (4) · Denmark (3) · Estonia (2) · Italy (2) · Argentina (1) · Brazil (1) · Czechia (1) · Greece (1) · Hong Kong (1) · Hungary (1) · Lithuania (1) · Puerto Rico (1) · Romania (1)
Jeri W Nieves, PhD (2) · Daniel Horwitz, MD (1) · David Lunardini, MD (1) · Emily Stein, MD (1) · Janet Crane, M.D. (1) · Jason Mendler, M.D. (1) · Joseph Lane, MD (1) · Neil Binkley, MD (1) · Willem Lems, Prof (1)
PMID 25393645, PMID 27533157, PMID 27612281, PMID 27826127, PMID 31411768, PMID 31674644, PMID 32513495, PMID 32658264, PMID 33434314, PMID 34231877, PMID 35524068, PMID 36588166, PMID 37417725, PMID 39999474, PMID 40786602, PMID 41812602, PMID 42618812, PMID 42781663